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httpcense.Abstract Introduction: Ichthyosis is a rare dermatological affection characterized by keratiniza-
tion disorder. The occurrence of acquired ichthyosis in adults is an indicator of systemic disease.
Ichthyosis can also reveal infectious diseases, or complicate medication. We report a case of ichthy-
osis secondary to isoniazid.
Case: A man aged 75 years was treated for pleural tuberculosis. At the 3rd month of treatment,
he develops cutaneous ichthyosis which regressed after discontinuation of antituberculous treat-
ment. The reintroduction of isoniazid did reappear cutaneous ichthyosis. The dosage adjustment
allows the improvement of lesions.
Discussion: Isoniazid may be a cause of cutaneous ichthyosis. Tuberculosis can promote it.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. Open access under CC BY-NC-ND license.Introduction
Ichthyosis is a group of cutaneous affections hereditary or ac-
quired, characterized by a disorder of keratinization. The term
ichthyosis is derived from a Greek word meaning ﬁsh because
the scales are arranged on the skin like ﬁsh scales. The ac-
quired ichthyosis may precede or accompany many systemic
diseases [1], or be a side effect of drug treatment [2]. We report
a case of ichthyosis secondary to isoniazid.6972786.
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A man aged 75 years, treated for pleural tuberculosis by the
ﬁxed combination of Rifampicin + Isoniazid + Pyrazina-
mide + Ethambutol. At the 3rd month of treatment, after
treatment with Rifampicin + Isoniazid he develops general-
ized scaly lesions lasting for 1 month in the context of dete-
rioration of his general condition with combined weight loss
of 5 kg, physical asthenia and anorexia. On physical exami-
nation, the patient was afebrile. On the mucocutaneous
check, it is pruriginous ichthyosis, with ﬁne and small squa-
mae, interesting trunk, upper and lower limbs (Figs. 1 and
2) but respecting hands and feet. We also noticed a dry
mouth, and cheilitis. The rest of the examination was unre-
markable including no organomegaly or lymphadenopathy
superﬁcial. The hemogram shows anemia: 10 g/dL, normo-
chromic normocytic and, lymphopenia: 880/mm3 and plate-
lets: 445000/mm3. There is a biological inﬂammatory
syndrome with CRP to 40 mg/L, ﬁbrinogen to 6 g/L, globu-
lin hyperalpha2 to 11 g/L, serum ferritin to 1990 mg/L andhe Egyptian Society of Chest Diseases and Tuberculosis.
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Figure 1 Ichthyosis in the two lower limbs.
Figure 2 Ichthyosis predominant in the trunk.
354 H. Kouismi et al.hypoalbuminemia to 30 g/L. Transaminases are normal, TP
to 90%. Computed tomography (CT) chest shows a right
pleural thickening without parenchymal lung nodule or ade-
nomegalies. Abdominal ultrasound is normal. Tumor mark-
ers are negative: aFP, ACE, CA19-9, PSA, NSE and
CYFRA 21. Serologic tests for HIV, HTLV-1 and syphilis
were negative. Research of Mycobacterium tuberculosis in
gastric aspirate and urine is negative. Antinuclear antibodies,
anti-native DNA, anti JO1 are negative, and thyroid and
parathyroid assessment were done.Ichthyosis lesions regressed after stoppage of ﬁfteen days of
antituberculous treatment, combined with vitamin B6, and
application of emollients on skin. The gradual reintroduction
of rifampicin passed without incident. But in the reintroduc-
tion of isoniazid, the patient had reappeared cutaneous lesions
of ichthyosis. The serum isoniazid objectiﬁed overdose, he was
under 300 mg/day (6 mg/kg), the adjusted dose is 100 mg/day,
dose adjustment allows the improvement of lesions.
Discussion
The acquired ichthyosis usually occurs in the elderly and is
witnessing an underlying systemic affection [1]. The list of
related diseases is long and varied: cancers [3], malignant
hemopathies (Hodgkin’s and non-Hodgkin’s, multiple mye-
loma) [4], infectious diseases (tuberculosis, leprosy, HIV,
infection HTLV-1: human T-cell lymphotropic virus type
1) [2,5], endocrinopathies (diabetes mellitus, hyperparathy-
roidism, hypothyroidism) [1,6] dysimmune diseases (lupus,
dermatopolymyositis, thyroiditis autoimmune) [7] granulo-
matosis (sarcoidosis, blau syndrome) [1,8], profound malnu-
trition or vitamin A deﬁciency [9], chronic renal failure.
Ichthyosis can also complicate drug treatment: allopurinol,
cimetidine, nicotinic acid, isoniazid, statins, clofazimine,
butyrophenones, dixyrazine [2].
Only two cases of ichthyosis revealing tuberculosis are de-
scribed [9,10]. No case of ichthyosis secondary to isoniazid
has been previously reported. It has not been demonstrated
that the ichthyosis was directly related to this drug or to tuber-
culosis itself. Malnutrition and important weight loss could
also be contributing factors.
Isoniazid was highly suspected because its reintroduction
caused the recurrence of the same lesion after disappearance
when treatment was stopped, the serum isoniazid was found
to be in overdose and dosage adjustment of isoniazid allowed
a good tolerance of the drug. In addition the vitamin B6 deﬁ-
ciency favored by isoniazid may participate in the generation
of the ichthyosis.
References
[1] J.J. DiGiovanna, L. Robinson-Bostom, Ichthyosis: etiology,
diagnosis, andmanagement,Am. J.Clin.Dermatol. 4 (2003) 81–95.
[2] F. Hali, A. Latiﬁ, M. Sbai, Une dermatose qui en re´ve`le une
autre, Revue de presse me´dicale 40 (2011) 455–457.
[3] Y.-J. Songa, Y.-F. Wua, T. Fanb, Dermatosis as the initial
manifestation of malignant breast tumors: retrospective analysis
of 4 cases, Breast Care 5 (2010) 174–176.
[4] R. Berrady, H. Baybay, Z. Khammar, M. Lahlou, L.
Lamchachti, S. Gallouj, A. El Hatimi, F.-Z. Merniossi, W.
Bono, Ichtyose acquise et he´mopathie maligne: Cinq
obervations, Ann. Dermatol. Venerol. 139 (2012) 9–14.
[5] A.L. Bittencourt, F. de Oliveira Mde, Cutaneous manifestations
associated with HTLV-1 infection, Int. J. Dermatol. 49 (10)
(2010).
[6] H. Sanli, B.N. Akay, B.B. Sen, A.Y. Kocak, R. Emral, S.
Bostanci, Acquired ichthyosis associated with type1diabetes
mellitus, Dermatoendocrinology 1 (2009) 34–36.
[7] V. Brazzelli, D. Larizza, F. Muzio, L. Fornara, V. Calcaterra, C.
Vassallo, F. Scaglia, G. Borroni, Acquired ichthyosis in a child
with autoimmune thyroiditis, Pediatr Dermatol. (4) (2010) 413–
414.
Cutaneous ichthyosis secondary to isoniazid 355[8] B.P. Kelley, D.E. George, T.M. LeLeux, S. Hsu, Ichthyosiform
sarcoidosis: a case report and review of the literature, Dermatol.
Online J. 16 (8) (2010) 5.
[9] M. Rabhi, K. Ennibi, S. Berady, J. Chaari, F. Toloune, Ichtyose
acquise re´ve´latrice d’une tuberculose he´patique et ganglionnaire,
Presse Med. 35 (2006) 1839–1841.[10] B. Vagamon, A. Dupuy, J. Fontaine, P. Guitera-Rovel, C.
Lebbe, P. Morel, M. Rybojad, Ichtyose acquise circine´e
re´ve´latrice d’une tuberculose ganglionnaire, Ann. Dermatol.
Venereol. 130 (2003) 635–637.
